Enovis Corporation filed its Form 10-Q for the quarterly period ended October 2, 2026, with the SEC on November 5, 2026, reporting third-quarter net sales of $558,725 thousand and a return to operating income after a large goodwill impairment charge in the year-ago period.
Key Highlights
- Net sales: $558,725 thousand for the three months ended October 2, 2026, compared with $548,912 thousand in the same period of 2025.
- Operating income: $3,375 thousand for the third quarter of 2026, versus an operating loss of $558,488 thousand in Q3 2025, which included a goodwill impairment charge of $548,442 thousand.
- Net income attributable to Enovis Corporation: $3,139 thousand for Q3 2026, compared with a net loss of $571,146 thousand in Q3 2025.
- Nine-month net sales: $1,730,658 thousand for the nine months ended October 2, 2026, versus $1,672,291 thousand for the nine months ended October 3, 2025.
- Shares outstanding: 57,694,806 shares of common stock as of October 30, 2026.
- Total assets: $3,735,544 thousand as of October 2, 2026, compared with $3,834,737 thousand at December 31, 2025.
- Long-term debt (less current portion): $1,223,261 thousand as of October 2, 2026, down from $1,261,793 thousand at December 31, 2025.
Enovis Corporation Financial Results for the Quarter Ended October 2, 2026
According to the filing, Enovis Corporation (NYSE:ENOV) reported net sales of $558,725 thousand for the three months ended October 2, 2026, up from $548,912 thousand in the comparable prior-year quarter. Gross profit for the quarter was $339,847 thousand, compared with $328,913 thousand a year earlier. Selling, general and administrative expense was $259,375 thousand, and research and development expense was $31,275 thousand, the filing disclosed.
The company reported operating income of $3,375 thousand in Q3 2026. The prior-year quarter reflected an operating loss of $558,488 thousand, which the filing attributed in part to a goodwill impairment charge of $548,442 thousand recorded in that period. No such charge was recorded in the current quarter, according to the filing. Net income (loss) per share from continuing operations was $0.02 basic and diluted for Q3 2026, versus $(9.99) in Q3 2025. For the nine months ended October 2, 2026, the company reported a net loss attributable to Enovis Corporation of $6,815 thousand, compared with a net loss of $663,851 thousand in the nine months ended October 3, 2025.
On the balance sheet, the filing reported total assets of $3,735,544 thousand as of October 2, 2026, with goodwill of $702,090 thousand and intangible assets, net, of $1,093,942 thousand. Cash and cash equivalents stood at $13,038 thousand, down from $36,389 thousand at December 31, 2025. Total equity was $1,495,583 thousand at quarter end, according to the filing. The company had 57,694,452 shares issued and outstanding as of October 2, 2026, with 133,333,333 shares authorized under its common stock, par value $0.001 per share.
What Was Disclosed
Enovis Corporation filed a 10-Q for the quarterly period ended October 2, 2026, disclosing third-quarter and year-to-date income statement results, balance sheet data as of quarter end, and equity activity for the first three quarters of fiscal 2026.




Please wait processing your request...